Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2016, Article ID 9506829, 14 pages
http://dx.doi.org/10.1155/2016/9506829
Research Article

Establishment of Relational Model of Congenital Heart Disease Markers and GO Functional Analysis of the Association between Its Serum Markers and Susceptibility Genes

1Department of Cardiovascular Medicine, The First Affiliated Hospital of Zhengzhou University, No. 1 East Jianshe Road, Zhengzhou 450052, China
2Department of Cardiovascular Medicine, Zhengzhou Central Hospital, Zhengzhou University, No. 195 Tongbai Road, Zhengzhou 450007, China
3Department of Ultrasound Diagnosis, Directly under Hospital of Henan Military Region, No. 18 Jinshui Road, Zhengzhou 450000, China

Received 3 August 2015; Revised 24 September 2015; Accepted 1 October 2015

Academic Editor: Krishna Agarwal

Copyright © 2016 Min Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Malik, M. A. Cleves, M. A. Honein et al., “Maternal smoking and congenital heart defects,” Pediatrics, vol. 121, no. 4, pp. e810–e816, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Dadvand, J. Rankin, S. Rushton, and T. Pless-Mulloli, “Association between maternal exposure toambient air pollution and congenital heart disease: a register-based sptiotemporal analysis,” American Journal of Epidemiology, vol. 173, no. 2, pp. 171–182, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Kučiene and V. Dulskiene, “Parental cigarette smoking and the risk of congenital heart septal defects,” Medicina, vol. 46, no. 9, pp. 635–641, 2010. View at Google Scholar · View at Scopus
  4. A. Miller, T. Riehle-Colarusso, C. Siffel, J. L. Frías, and A. Correa, “Maternal age and prevalence of isolated congenital heart defects in an urban area of the United States,” American Journal of Medical Genetics A, vol. 155, no. 9, pp. 2137–2145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. L. A. Lisowski, P. M. Verheijen, J. A. Copel et al., “Congenital heart disease in pregnancies complicated by maternal diabetes mellitus: an international clinical collaboration, literature review, and meta-analysis,” Herz, vol. 35, no. 1, pp. 19–26, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. L. L. Lipscombe, A. T. Banerjee, S. McTavish et al., “Readiness for diabetes prevention and barriers to lifestyle change in women with a history of gestational diabetes mellitus: rationale and study design,” Diabetes Research and Clinical Practice, vol. 106, no. 1, pp. 57–66, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Pejtsik, J. Pintér, M. Horváth, and J. Hadnagy, “Relationship between congenital heart disease and various factors affecting pregnancy,” Orvosi Hetilap, vol. 133, no. 3, pp. 155–158, 1992. View at Google Scholar · View at Scopus
  8. P. Pradat, C. Francannet, J. A. Harris, and E. Robert, “The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations,” Pediatric Cardiology, vol. 24, no. 3, pp. 195–221, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Hu, X. Yuan, K. Rao, Z. Zheng, and S. Hu, “National trend in congenital heart disease mortality in China during 2003 to 2010: a population-based study,” Journal of Thoracic and Cardiovascular Surgery, vol. 148, no. 2, pp. 596–602, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. V. N. Vapnik, The Nature of Statistical Learning Theory, Springer, Berlin, Germany, 2nd edition, 1999.
  11. X. Song and N.-K. Chen, “A SVM-based quantitative fMRI method for resting-state functional network detection,” Magnetic Resonance Imaging, vol. 32, no. 7, pp. 819–831, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Pikkarainen, H. Tokola, R. Kerkelä, and H. Ruskoaho, “GATA transcription factors in the developing and adult heart,” Cardiovascular Research, vol. 63, no. 2, pp. 196–207, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Zhao, X. Y. Zhu, X. L. Tian et al., “Detection of mutation in ZFPM2/FOG2 gene coding region in patients of Tetralogy of Fallot,” Chinese Journal of Cardiovascular Research, vol. 10, pp. 422–424, 2012. View at Google Scholar
  14. W. Huang, H. Meng, Y. Qiao, S. Pang, D. Chen, and B. Yan, “Two novel and functional DNA sequence variants within an upstream enhancer of the human NKX2-5 gene in ventricular septal defects,” Gene, vol. 524, no. 2, pp. 152–155, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Xiong, Q. Li, C. Zhang et al., “Analyses of GATA4, NKX2.5, and TFAP2B genes in subjects from southern China with sporadic congenital heart disease,” Cardiovascular Pathology, vol. 22, no. 2, pp. 141–145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Pang, J. Shan, Y. Qiao et al., “Genetic and functional analysis of the NKX2-5 gene promoter in patients with ventricular septal defects,” Pediatric Cardiology, vol. 33, no. 8, pp. 1355–1361, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Fang, Exploration of the Transcription Factor NKX2.5 and GATA4 in Patients with Congenital Heart Disease, Southeast University, 2011.
  18. T. Peng, L. Wang, S.-F. Zhou, and X. Li, “Mutations of the GATA4 and NKX2.5 genes in Chinese pediatric patients with non-familial congenital heart disease,” Genetica, vol. 138, no. 11, pp. 1231–1240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J.-D. Ding, K.-R. Li, X.-L. Zhang et al., “Preliminary exploration of transcription factor Nkx2.5 mutations and congenital heart diseases,” National Medical Journal of China, vol. 89, no. 16, pp. 1114–1116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. K. R. Li, J. D. Ding, X. L. Zhang, Y. Y. Yao, L. Q. Ren, and G. S. Ma, “Observation of transcription factor Nkx2.5 mutations of congenital heart disease patients,” Shandong Medical Journal, vol. 48, pp. 83–84, 2008. View at Google Scholar
  21. C. Cheng, Y. Lin, F. Yang et al., “Mutational screening of affected cardiac tissues and peripheral blood cells identified novel somatic mutations in GATA4 in patients with ventricular septal defect,” Journal of Biomedical Research, vol. 25, no. 6, pp. 425–430, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. W.-M. Zhang, X.-F. Li, Z.-Y. Ma et al., “GATA4 and NKX2.5 gene analysis in Chinese Uygur patients with congenital heart disease,” Chinese Medical Journal, vol. 122, no. 4, pp. 416–419, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. B. B. Dong, G. F. Zheng, H. Zhao, D. Wei, and X. Y. Liu, “Mutational analysis of the GATA4 gene in patients with congenital heart disease,” International Journal of Cardiovascular Disease, vol. 39, pp. 48–52, 2012. View at Google Scholar
  24. Y. Q. Yang, Y. Q. Tang, and X. Y. Liu, “A novel GATA4 mutation leading to congenital heart disease ventricular septal defect,” Chinese Journal of Medical Genetics, vol. 27, pp. 512–516, 2010. View at Google Scholar
  25. X. Y. Liu, Y. Q. Yang, J. Ma, X. P. Lin, and Y. H. Chen, “Novel GATA4 mutations in patients with congenital ventricular septal defects,” Chinese Journal of Laboratory Medicine, vol. 33, pp. 343–347, 2010. View at Google Scholar
  26. X. P. Lin and Y. H. Chen, “GATA4 mutations and sporadic congenital heart disease,” Journal of Tongji University, vol. 30, pp. 9–13, 2009. View at Google Scholar
  27. M. W. Chen, Screening and Functional Analysis of GATA-4 Mutations in Congenital Cardiac Septal Defects, Guangxi Medical University, 2009.
  28. Z.-H. Tang, L. Xia, W. Chang et al., “Two novel missense mutations of GATA4 gene in Chinese patients with sporadic congenital heart defects,” Zhonghua Yi Xue Yi Chuan Xue Za Zhi, vol. 23, no. 2, pp. 134–137, 2006. View at Google Scholar · View at Scopus
  29. W. Zhang, L. Shen, Z. Deng et al., “Novel missense variants of ZFPM2/FOG2 identified in conotruncal heart defect patients do not impair interaction with GATA4,” PLoS ONE, vol. 9, no. 7, Article ID e102379, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. Z.-P. Tan, C. Huang, Z.-B. Xu, J.-F. Yang, and Y.-F. Yang, “Novel ZFPM2/FOG2 variants in patients with double outlet right ventricle,” Clinical Genetics, vol. 82, no. 5, pp. 466–471, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. A. De Luca, A. Sarkozy, R. Ferese et al., “New mutations in ZFPM2/FOG2 gene in tetralogy of Fallot and double outlet right ventricle,” Clinical Genetics, vol. 80, no. 2, pp. 184–190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Guo, “Clinical value of heart color-ultrasonography combined measurement of serum cTnI, IGF-I and IGFBP-3 levels in patients with congenital heart diseases,” Journal of Radioimmunology, vol. 24, no. 5, pp. 500–502, 2011. View at Google Scholar
  33. H. Sha, Q. Li, W. Qian, H. Li, and G. Q. Chen, “Evaluation of cardiac function by H-FABP, NT-proBNP, cTnI in children with congenital heart diseases and pneumonia,” Chinese Journal of Pediatrics, vol. 29, pp. 939–941, 2011. View at Google Scholar
  34. A. Uner, M. Doğan, M. Ay, and Ç. Acar, “The evaluation of serum N-terminal prohormone brain-type natriuretic peptide, troponin-I, and high-sensitivity C-reactive protein levels in children with congenital heart disease,” Human and Experimental Toxicology, vol. 33, no. 11, pp. 1158–1166, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. F.-J. Zhou, C.-Y. Zhou, Y.-J. Tian et al., “Diagnostic value of analysis of H-FABP, NT-proBNP, and cTnI in heart function in children with congenital heart disease and pneumonia,” European Review for Medical and Pharmacological Sciences, vol. 18, no. 10, pp. 1513–1516, 2014. View at Google Scholar · View at Scopus
  36. H. Tomita, M. Takamuro, W. Soda, K. Hatakeyama, and H. Tsutsumi, “Increased serum high-sensitivity C-reactive protein is related to hypoxia and brain natriuretic peptide in congenital heart disease,” Pediatrics International, vol. 50, no. 4, pp. 436–440, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. X. F. Guang, H. L. Dai, C. H. Zhang et al., “Study of the changes of serum BNP, VEGF, and hs-CRP in patients with congenital heart disease combined with pulmonary arterial hypertension,” Chinese Journal of Clinicians, vol. 6, pp. 891–893, 2012. View at Google Scholar
  38. S. Yang, Clinical Research of the Value of Measurement of Plasma Brain Natriuretic Peptide and High Sensitive C-Reactive Protein in Congenital Heart Disease, Hebei Medical University, 2012.
  39. X. J. Zhao, Y. L. Geng, Z. L. Chen, G. X. Wang, J. Zhao, and X. B. Li, “Clinical analysis of serum hs-CRP and BNP levels of children with blue type congenital heart disease,” Hebei Medical Journal, vol. 36, pp. 1790–1792, 2014. View at Google Scholar
  40. W. Li, Clinical significance and changes in copeptin, brain natriuretic peptide and C-reactive protein concentration on peripheral blood in children with congenital heart disease combined with heart failure [M.S. thesis], Qingdao University, Qingdao, China, 2014.
  41. X. N. Wang, S. B. Yang, X. Y. Tian et al., “Clinical value of C-reactive protein combined with B-type natriuretic peptide in evaluation of cardiac function of congenital heart disease children with pulmonary infections,” Chinese Journal of Nosocomiology, vol. 24, pp. 1263–1264, 2014. View at Google Scholar
  42. X. L. Lin and H. P. Liu, “Clinical analysis of C-reactive protein and B-type natriuretic peptide assessment of cardiac function in congenital heart disease children with lung infections,” The Journal of Medical Theory & Practice, vol. 27, pp. 2001–2002, 2014. View at Google Scholar
  43. Y. Qiu, X. L. Huang, J. Wu, H. Zheng, W. S. Wu, and Z. Lin, “Plasma brain natriuretic peptide and Tei index assessment of heart function in children with left to right congenital heart defects,” Maternal and Child Health Care of China, vol. 22, pp. 2209–2211, 2007. View at Google Scholar
  44. B. Y. Meng, T. Wang, Q. Zhang et al., “Brain natriuretic peptide and Tei-index for assessing preoperative left heart function in infants with congenital heart diseases,” South China Journal of Cardiovascular Diseases, vol. 16, pp. 378–381, 2010. View at Google Scholar
  45. J. Hu, H. Sha, and Q. Li, “The change of serum levels of B-type natriuretic peptides and the correlation to children with congenital heart disease and serious pnenmonia,” Chinese Medicine, vol. 6, pp. 1402–1403, 2011. View at Google Scholar
  46. X. Li, M. Y. Yang, J. T. Qin, Y. Lin, D. Wang, and C. Y. Wang, “Relationship of serum N-terminal pro-brain natriuretic peptide and pulmonary artery pressure in pediatric patients with congenital heart disease,” Hainan Medical Journal, vol. 23, no. 1, pp. 84–85, 2012. View at Google Scholar
  47. X. Li, M. Y. Yang, J. T. Qin et al., “Clinical significance of changes of plasma N-terminal pro-brain natriuretic peptide in children with congenital heart disease combined with heart failure,” Journal of Applied Clinical Pediatrics, vol. 27, pp. 19–20, 2012. View at Google Scholar
  48. H. L. Wang and X. R. A, “Clinical significance of plasma BNP testing of children with congenital heart disease in plateau area,” Laboratory Medicine, vol. 28, pp. 865–866, 2013. View at Google Scholar
  49. M. Kavga, G. Varlamis, A. Giannopoulos et al., “Correlation of plasma B-type natriuretic peptide with shunt volume in children with congenital heart disease involving left-to-right shunt,” Hellenic Journal of Cardiology, vol. 54, no. 3, pp. 192–198, 2013. View at Google Scholar · View at Scopus
  50. J. M. Fang, W. Guo, J. Jiang, L. F. Yu, and Y. Y. Guo, “Symptoms and clinical significance of N-terminal pro-brain natriuretic peptide in children suffering from congenital heart disease combined with heart failure,” China Medical Herald, vol. 10, pp. 43–45, 2013. View at Google Scholar
  51. C.-W. Lin, X.-L. Zeng, X.-H. Meng, S.-H. Jiang, and H. Ou-Yang, “Clinical importance of preoperative measurement of plasma amino-terminal pro-B-type natriuretic peptide in infants with congenital heart disease,” Chinese Journal of Contemporary Pediatrics, vol. 16, no. 1, pp. 40–43, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. D. B. McElhinney, E. Geiger, J. Blinder, D. W. Benson, and E. Goldmuntz, “NKX2.5 mutations in patients with congenital heart disease,” Journal of the American College of Cardiology, vol. 42, no. 9, pp. 1650–1655, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. V. Garg, I. S. Kathiriya, R. Barnes et al., “GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5,” Nature, vol. 424, no. 6947, pp. 443–447, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Geiger, A. Hammerer-Lercher, C. Url et al., “NT-proBNP concentrations indicate cardiac disease in pediatric patients,” International Journal of Cardiology, vol. 123, no. 1, pp. 63–65, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. E. Akhabue, J. Thiboutot, J.-W. Cheng et al., “New and emerging risk factors for coronary heart disease,” The American Journal of the Medical Sciences, vol. 347, no. 2, pp. 151–158, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Bennet, E. Di Angelantonio, S. Erqou et al., “Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data,” Archives of Internal Medicine, vol. 168, no. 6, pp. 598–608, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. P. R. Kamstrup, M. Benn, A. Tybjærg-Hansen, and B. G. Nordestgaard, “Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study,” Circulation, vol. 117, no. 2, pp. 176–184, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. Momiyama, R. Ohmori, Z. A. Fayad et al., “Associations between serum lipoprotein(a) levels and the severity of coronary and aortic atherosclerosis,” Atherosclerosis, vol. 222, no. 1, pp. 241–244, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Jiang, K. Guo, M. Chen, J. Bao, C. Shen, and Y. Li, “Serum lipoprotein(a) positively correlates with coronary artery calcification in low-risk Chinese Han patients: a study from a single center,” PLoS ONE, vol. 8, no. 8, Article ID e71673, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Charron, P. Paradis, O. Bronchain, G. Nemer, and M. Nemer, “Cooperative interaction between GATA-4 and GATA-6 regulates myocardial gene expression,” Molecular and Cellular Biology, vol. 19, no. 6, pp. 4355–4365, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Salazar, F. Consoli, V. Villegas et al., “Search of somatic GATA4 and NKX2.5 gene mutations in sporadic septal heart defects,” European Journal of Medical Genetics, vol. 54, no. 3, pp. 306–309, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. T. M. Chlon and J. D. Crispino, “Combinatorial regulation of tissue specification by GATA and FOG factors,” Development, vol. 139, no. 21, pp. 3905–3916, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. F. Malek, J. Dvorak, J. Svitil et al., “Correlation of lipoprotein(a) concentration with the extent of coronary artery disease in patients on lipid lowering therapy,” Neuro Endocrinology Letters, vol. 2, pp. 55–59, 2012. View at Google Scholar
  64. M. Greif, T. Arnoldt, F. von Ziegler et al., “Lipoprotein(a) is independently correlated with coronary artery calcification,” European Journal of Internal Medicine, vol. 24, no. 1, pp. 75–79, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. Z.-G. Li, G. Li, Y.-L. Zhou et al., “Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention,” Lipids in Health and Disease, vol. 12, article 127, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. H. Konishi, K. Miyauchi, T. Kasai et al., “Impact of lipoprotein(a) as residual risk on long-term outcomes in patients after percutaneous coronary intervention,” American Journal of Cardiology, vol. 115, no. 2, pp. 157–160, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. V. Gudnason, “Lipoprotein (a): a causal independent risk factor for coronary heart disease?” Current Opinion in Cardiology, vol. 24, no. 5, pp. 490–495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. A. von Zychlinski, T. Kleffmann, M. J. A. Williams, and S. P. McCormick, “Proteomics of Lipoprotein(a) identifies a protein complement associated with response to wounding,” Journal of Proteomics, vol. 74, no. 12, pp. 2881–2891, 2011. View at Publisher · View at Google Scholar · View at Scopus